Differential response to α-oxoaldehydes in tamoxifen resistant MCF-7 breast cancer cells.
Tamoxifen is the standard adjuvant endocrine therapy for estrogen-receptor positive premenopausal breast cancer patients. However, tamoxifen resistance is frequently observed under therapy. A tamoxifen resistant cell line has been generated from the estrogen receptor positive mamma carcinoma cell li...
Main Authors: | Norbert Nass, Hans-Jürgen Brömme, Roland Hartig, Sevil Korkmaz, Saadettin Sel, Frank Hirche, Aoife Ward, Andreas Simm, Stefan Wiemann, Anne E Lykkesfeldt, Albert Roessner, Thomas Kalinski |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24983248/pdf/?tool=EBI |
Similar Items
-
Correction: Differential Response to α-Oxoaldehydes in Tamoxifen Resistant MCF-7 Breast Cancer Cells
by: The Staff
Published: (2014-01-01) -
Correction: Differential Response to α-Oxoaldehydes in Tamoxifen Resistant MCF-7 Breast Cancer Cells.
Published: (2014-01-01) -
Curcumin blocks interleukin-1 signaling in chondrosarcoma cells.
by: Thomas Kalinski, et al.
Published: (2014-01-01) -
Studies on the formation, metabolism and glycation reactions of endogenous and exogenous alpha-oxoaldehydes in uraemia
by: Agalou, Stamatina
Published: (2005) -
G-Protein-Coupled Estrogen Receptor (GPER)-Specific Agonist G1 Induces ER Stress Leading to Cell Death in MCF-7 Cells
by: Diep-Khanh Ho Vo, et al.
Published: (2019-09-01)